Published online before print October 14, 2004, doi: 10.1161/01.RES.0000147557.75257.ff
© 2004 American Heart Association, Inc.
Molecular Medicine |
Silent Information Regulator 2
, a Longevity Factor and Class III Histone Deacetylase, Is an Essential Endogenous Apoptosis Inhibitor in Cardiac Myocytes
From the Cardiovascular Research Institute, Department of Cell Biology and Molecular Medicine (R.R.A., S.F.V., J.S.), University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark; the Department of Physiology (L.A.K.), Faculty of Medicine, Institute of Cardiovascular Sciences, St. Boniface General Hospital Research Center, University of Manitoba, Winnipeg, Canada; and the Department of Molecular Biology and Pharmacology (S.I.), Washington University School of Medicine, St. Louis, Mo.
Correspondence to Junichi Sadoshima MD, PhD, Cardiovascular Research Institute, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, 185 S Orange Ave, MSB G-609, Newark, NJ 07103. E-mail Sadoshju{at}umdnj.edu
Yeast silent information regulator 2 (Sir2), a nicotinamide adenine dinucleotide–dependent histone deacetylase (HDAC) and founding member of the HDAC class III family, functions in a wide array of cellular processes, including gene silencing, longevity, and DNA damage repair. We examined whether or not the mammalian ortholog Sir2 affects growth and death of cardiac myocytes. Cardiac myocytes express Sir2
predominantly in the nucleus. Neonatal rat cardiac myocytes were treated with 20 mmol/L nicotinamide (NAM), a Sir2 inhibitor, or 50 nmol/L Trichostatin A (TSA), a class I and II HDAC inhibitor. NAM induced a significant increase in nuclear fragmentation (2.2-fold) and cleaved caspase-3, as did sirtinol, a specific Sir2 inhibitor, and expression of dominant-negative Sir2. TSA also modestly increased cell death (1.5-fold) but without accompanying caspase-3 activation. Although TSA induced a 1.5-fold increase in cardiac myocyte size and protein content, NAM reduced both. In addition, NAM caused acetylation and increases in the transcriptional activity of p53, whereas TSA did not. NAM-induced cardiac myocyte apoptosis was inhibited in the presence of dominant-negative p53, suggesting that Sir2 inhibition causes apoptosis through p53. Overexpression of Sir2 protected cardiac myocytes from apoptosis in response to serum starvation and significantly increased the size of cardiac myocytes. Furthermore, Sir2 expression was increased significantly in hearts from dogs with heart failure induced by rapid pacing superimposed on stable, severe hypertrophy. These results suggest that endogenous Sir2 plays an essential role in mediating cell survival, whereas Sir2 overexpression protects myocytes from apoptosis and causes modest hypertrophy. In contrast, inhibition of endogenous class I and II HDACs primarily causes cardiac myocyte hypertrophy and also induces modest cell death. An increase in Sir2 expression during heart failure suggests that Sir2 may play a cardioprotective role in pathologic hearts in vivo.
Key Words: histone deacetylase • Sir2 • p53 • apoptosis • cardiac hypertrophy
This article has been cited by other articles:
 |
|
 |
|
  M.C. Zillikens, J. B.J. van Meurs, F. Rivadeneira, N. Amin, A. Hofman, B. A. Oostra, E. J.G. Sijbrands, J. C.M. Witteman, H. A.P. Pols, C. M. van Duijn, et al. SIRT1 Genetic Variation Is Related to BMI and Risk of Obesity Diabetes, December 1, 2009; 58(12): 2828 - 2834. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Lu, I. Scott, B. R. Webster, and M. N. Sack The Emerging Characterization of Lysine Residue Deacetylation on the Modulation of Mitochondrial Function and Cardiovascular Biology Circ. Res., October 23, 2009; 105(9): 830 - 841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-P. Hsu, S. Oka, D. Shao, N. Hariharan, and J. Sadoshima Nicotinamide Phosphoribosyltransferase Regulates Cell Survival Through NAD+ Synthesis in Cardiac Myocytes Circ. Res., August 28, 2009; 105(5): 481 - 491. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Shinmura, K. Tamaki, and R. Bolli Impact of 6-mo caloric restriction on myocardial ischemic tolerance: possible involvement of nitric oxide-dependent increase in nuclear Sirt1 Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2348 - H2355. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Granger, I. Abdullah, F. Huebner, A. Stout, T. Wang, T. Huebner, J. A. Epstein, and P. J. Gruber Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice FASEB J, October 1, 2008; 22(10): 3549 - 3560. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Hou, S. Xu, K. A. Maitland-Toolan, K. Sato, B. Jiang, Y. Ido, F. Lan, K. Walsh, M. Wierzbicki, T. J. Verbeuren, et al. SIRT1 Regulates Hepatocyte Lipid Metabolism through Activating AMP-activated Protein Kinase J. Biol. Chem., July 18, 2008; 283(29): 20015 - 20026. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Miyazaki, T. Ichiki, T. Hashimoto, K. Inanaga, I. Imayama, J. Sadoshima, and K. Sunagawa SIRT1, a Longevity Gene, Downregulates Angiotensin II Type 1 Receptor Expression in Vascular Smooth Muscle Cells Arterioscler Thromb Vasc Biol, July 1, 2008; 28(7): 1263 - 1269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Vakhrusheva, C. Smolka, P. Gajawada, S. Kostin, T. Boettger, T. Kubin, T. Braun, and E. Bober Sirt7 Increases Stress Resistance of Cardiomyocytes and Prevents Apoptosis and Inflammatory Cardiomyopathy in Mice Circ. Res., March 28, 2008; 102(6): 703 - 710. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Pillai, M. Chen, S. B. Rajamohan, S. Samant, V. B. Pillai, M. Gupta, and M. P. Gupta Activation of SIRT1, a class III histone deacetylase, contributes to fructose feeding-mediated induction of the {alpha}-myosin heavy chain expression Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1388 - H1397. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kuningas, M. Putters, R. G. J. Westendorp, P. E. Slagboom, and D. van Heemst SIRT1 Gene, Age-Related Diseases, and Mortality: The Leiden 85-Plus Study J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2007; 62(9): 960 - 965. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Hara, K. Yamada, T. Shibata, H. Osago, T. Hashimoto, and M. Tsuchiya Elevation of Cellular NAD Levels by Nicotinic Acid and Involvement of Nicotinic Acid Phosphoribosyltransferase in Human Cells J. Biol. Chem., August 24, 2007; 282(34): 24574 - 24582. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Menna, E. Salvatorelli, and G. Minotti Doxorubicin Degradation in Cardiomyocytes J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 408 - 419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Sedding and J. Haendeler Do We Age on Sirt1 Expression? Circ. Res., May 25, 2007; 100(10): 1396 - 1398. [Full Text] [PDF]
|
|
|
|
|
|
R. R. Alcendor, S. Gao, P. Zhai, D. Zablocki, E. Holle, X. Yu, B. Tian, T. Wagner, S. F. Vatner, and J. Sadoshima Sirt1 Regulates Aging and Resistance to Oxidative Stress in the Heart Circ. Res., May 25, 2007; 100(10): 1512 - 1521. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. McKinsey Derepression of pathological cardiac genes by members of the CaM kinase superfamily Cardiovasc Res, March 1, 2007; 73(4): 667 - 677. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Anastasiou and W. Krek SIRT1: Linking Adaptive Cellular Responses to Aging-Associated Changes in Organismal Physiology. Physiology, December 1, 2006; 21(6): 404 - 410. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Qin, T. Yang, L. Ho, Z. Zhao, J. Wang, L. Chen, W. Zhao, M. Thiyagarajan, D. MacGrogan, J. T. Rodgers, et al. Neuronal SIRT1 Activation as a Novel Mechanism Underlying the Prevention of Alzheimer Disease Amyloid Neuropathology by Calorie Restriction J. Biol. Chem., August 4, 2006; 281(31): 21745 - 21754. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I.-Y. Chen, J. Lypowy, J. Pain, D. Sayed, S. Grinberg, R. R. Alcendor, J. Sadoshima, and M. Abdellatif Histone H2A.z Is Essential for Cardiac Myocyte Hypertrophy but Opposed by Silent Information Regulator 2{alpha} J. Biol. Chem., July 14, 2006; 281(28): 19369 - 19377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Kong, P. Tannous, G. Lu, K. Berenji, B. A. Rothermel, E. N. Olson, and J. A. Hill Suppression of Class I and II Histone Deacetylases Blunts Pressure-Overload Cardiac Hypertrophy Circulation, June 6, 2006; 113(22): 2579 - 2588. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Pedram, C. N. Sprung, Q. Gao, A. W. I. Lo, G. E. Reynolds, and J. P. Murnane Telomere Position Effect and Silencing of Transgenes near Telomeres in the Mouse. Mol. Cell. Biol., March 1, 2006; 26(5): 1865 - 1878. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Chen, D. M. Nelson, and Y. Sadovsky N-Myc Down-regulated Gene 1 Modulates the Response of Term Human Trophoblasts to Hypoxic Injury J. Biol. Chem., February 3, 2006; 281(5): 2764 - 2772. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Backs and E. N. Olson Control of Cardiac Growth by Histone Acetylation/Deacetylation Circ. Res., January 6, 2006; 98(1): 15 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. Kee, I. S. Sohn, K. I. Nam, J. E. Park, Y. R. Qian, Z. Yin, Y. Ahn, M. H. Jeong, Y.-J. Bang, N. Kim, et al. Inhibition of Histone Deacetylation Blocks Cardiac Hypertrophy Induced by Angiotensin II Infusion and Aortic Banding Circulation, January 3, 2006; 113(1): 51 - 59. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Pillai, A. Isbatan, S.-i. Imai, and M. P. Gupta Poly(ADP-ribose) Polymerase-1-dependent Cardiac Myocyte Cell Death during Heart Failure Is Mediated by NAD+ Depletion and Reduced Sir2{alpha} Deacetylase Activity J. Biol. Chem., December 30, 2005; 280(52): 43121 - 43130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Liu, R. Colavitti, I. I. Rovira, and T. Finkel Redox-Dependent Transcriptional Regulation Circ. Res., November 11, 2005; 97(10): 967 - 974. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Crow Sirviving Cardiac Stress: Cardioprotection Mediated by a Longevity Gene Circ. Res., November 12, 2004; 95(10): 953 - 956. [Full Text] [PDF]
|
|